Skip to main content
Top
Published in: Annals of Intensive Care 1/2018

Open Access 01-12-2018 | Review

Albumin infusion in spontaneous bacterial peritonitis: another brick off the wall?

Authors: Damien Roux, Richard Moreau, Didier Dreyfuss

Published in: Annals of Intensive Care | Issue 1/2018

Login to get access

Excerpt

Albumin infusion did not convey any survival benefit compared to normal saline in a randomized controlled study (RCT) which involved a very large population of ICU patients who required intravascular fluid resuscitation [1]. There was, however, a nonsignificant trend in favor of albumin in patients with severe sepsis [2]. This trend was contradicted in another RCT which did not show any difference in mortality when albumin was added to normal saline during severe sepsis or septic shock compared with saline alone [3]. Post hoc analyses, with their inherent limitation, suggested a trend for higher mortality in patients with severe sepsis without shock who received albumin and a significant reduction in mortality with albumin in patients with septic shock [3]. A conservative conclusion of all these studies is the lack of strong evidence in favor of albumin during sepsis without shock. …
Literature
1.
go back to reference Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350:2247–56.CrossRef Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350:2247–56.CrossRef
2.
go back to reference SAFE Study Investigators, Finfer S, McEvoy S, Bellomo R, McArthur C, Myburgh J, et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med. 2011;37:86–96.CrossRef SAFE Study Investigators, Finfer S, McEvoy S, Bellomo R, McArthur C, Myburgh J, et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med. 2011;37:86–96.CrossRef
3.
go back to reference Caironi P, Tognoni G, Masson S, Fumagalli R, Pesenti A, Romero M, et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014;370:1412–21.CrossRef Caironi P, Tognoni G, Masson S, Fumagalli R, Pesenti A, Romero M, et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014;370:1412–21.CrossRef
4.
go back to reference Angeli P, Bernardi M, Villanueva C, Francoz C, Mookerjee RP, Trebicka J, et al. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406–60.CrossRef Angeli P, Bernardi M, Villanueva C, Francoz C, Mookerjee RP, Trebicka J, et al. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406–60.CrossRef
5.
go back to reference Caraceni P, Angeli P, Prati D, Bernardi M, Alessandria C, Riggio O, et al. AISF-SIMTI position paper: the appropriate use of albumin in patients with liver cirrhosis. Dig Liver Dis. 2016;48:4–15.CrossRef Caraceni P, Angeli P, Prati D, Bernardi M, Alessandria C, Riggio O, et al. AISF-SIMTI position paper: the appropriate use of albumin in patients with liver cirrhosis. Dig Liver Dis. 2016;48:4–15.CrossRef
6.
go back to reference Moore KP. Guidelines on the management of ascites in cirrhosis. Gut. 2006;55:1–12.CrossRef Moore KP. Guidelines on the management of ascites in cirrhosis. Gut. 2006;55:1–12.CrossRef
7.
go back to reference Freedman B. Equipoise and the ethics of clinical research. N Engl J Med. 1987;317:141–5.CrossRef Freedman B. Equipoise and the ethics of clinical research. N Engl J Med. 1987;317:141–5.CrossRef
8.
go back to reference Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999;341:403–9.CrossRef Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999;341:403–9.CrossRef
9.
go back to reference Salerno F, Navickis RJ, Wilkes MM. Albumin infusion improves outcomes of patients with spontaneous bacterial peritonitis: a meta-analysis of randomized trials. Clin Gastroenterol Hepatol. 2013;11(123–130):e1. Salerno F, Navickis RJ, Wilkes MM. Albumin infusion improves outcomes of patients with spontaneous bacterial peritonitis: a meta-analysis of randomized trials. Clin Gastroenterol Hepatol. 2013;11(123–130):e1.
10.
go back to reference Xue HP, Lin B, Mo JZ, Li JQ. Effect of albumin infusion on preventing the deterioration of renal function in patients with spontaneous bacterial peritonitis. Chin J Dig Dis. 2002;3:32–4.CrossRef Xue HP, Lin B, Mo JZ, Li JQ. Effect of albumin infusion on preventing the deterioration of renal function in patients with spontaneous bacterial peritonitis. Chin J Dig Dis. 2002;3:32–4.CrossRef
11.
go back to reference Chen T-A, Tsao Y-C, Chen A, Lo G-H, Lin C-K, Yu H-C, et al. Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis. Scand J Gastroenterol. 2009;44:619–25.CrossRef Chen T-A, Tsao Y-C, Chen A, Lo G-H, Lin C-K, Yu H-C, et al. Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis. Scand J Gastroenterol. 2009;44:619–25.CrossRef
12.
go back to reference Mutter TC, Ruth CA, Dart AB. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev. 2013;CD007594. Mutter TC, Ruth CA, Dart AB. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev. 2013;CD007594.
13.
go back to reference American Society of Clinical Oncology. policy for relationships with companies. J Clin Oncol. 2017;35:796–8.CrossRef American Society of Clinical Oncology. policy for relationships with companies. J Clin Oncol. 2017;35:796–8.CrossRef
14.
go back to reference Fernández J, Monteagudo J, Bargallo X, Jiménez W, Bosch J, Arroyo V, et al. A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis. Hepatology. 2005;42:627–34.CrossRef Fernández J, Monteagudo J, Bargallo X, Jiménez W, Bosch J, Arroyo V, et al. A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis. Hepatology. 2005;42:627–34.CrossRef
15.
go back to reference Guevara M, Terra C, Nazar A, Solà E, Fernández J, Pavesi M, et al. Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis: a randomized, controlled study. J Hepatol. 2012;57:759–65.CrossRef Guevara M, Terra C, Nazar A, Solà E, Fernández J, Pavesi M, et al. Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis: a randomized, controlled study. J Hepatol. 2012;57:759–65.CrossRef
16.
go back to reference Thévenot T, Bureau C, Oberti F, Anty R, Louvet A, Plessier A, et al. Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis: a randomized trial. J Hepatol. 2015;62:822–30.CrossRef Thévenot T, Bureau C, Oberti F, Anty R, Louvet A, Plessier A, et al. Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis: a randomized trial. J Hepatol. 2015;62:822–30.CrossRef
Metadata
Title
Albumin infusion in spontaneous bacterial peritonitis: another brick off the wall?
Authors
Damien Roux
Richard Moreau
Didier Dreyfuss
Publication date
01-12-2018
Publisher
Springer International Publishing
Published in
Annals of Intensive Care / Issue 1/2018
Electronic ISSN: 2110-5820
DOI
https://doi.org/10.1186/s13613-018-0450-2

Other articles of this Issue 1/2018

Annals of Intensive Care 1/2018 Go to the issue